id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1144318,976e97e4-f83b-4a20-903f-b2aed96a399b,Q3,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2011,third_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2011-10-02T22:00:56.330000-04:00
1144331,dd36764f-1fd6-45f0-9974-b35b2072a82d,Q3,MARSHALL BRACHMAN,6848,CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE,2011,third_quarter,MED,reverse cardiac catheterization practice expense cuts,"HOUSE OF REPRESENTATIVES,SENATE",12000,,0,0,2011-10-02T22:10:59.360000-04:00
1144484,6b94c7f8-f4cb-4523-9af6-5c84d4f80955,Q3,"TAKEDA PHARMACEUTICALS AMERICA, INC.",57954,TAKEDA PHARMACEUTICALS AMERICA INC,2011,third_quarter,MED,"Regenerative Medicines Promotion Act; Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 2239); depression screening, end stage renal disease;","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE,Treasury, Dept of",,400000,0,0,2011-10-03T13:54:18.780000-04:00
1144716,832e7946-b07c-4123-949a-2892f9fde929,Q3,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,"VIJUK EQUIPMENT, INC.",2011,third_quarter,MED,all issues relating to pharmaceutical labeling,,25000,,0,0,2011-10-04T13:05:54.343000-04:00
1144722,6b137de3-e6d0-4171-91f6-49f72eb0d2c2,Q3,THE HARRIS FIRM,68376,DIRECT MESSAGE LAB,2011,third_quarter,MED,Regarding funding for FY 11 pertaining to software communication system for chronic disease management,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2011-10-04T13:26:58.840000-04:00
1144766,4c48f14c-b905-43bf-aca0-8f03e3035426,Q3,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),1466,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),2011,third_quarter,MED,"AACC joined with Members of the Clinical Laboratory Coalition in writing to Members of the House and Senate in opposing the adoption of a clinical laboratory co-payment as part of any debt reduction package.
AACC joined with Members of the Clinical Laboratory Coalition in writing to members of the Joint Select Committee on Deficit Reduction in opposition to a clinical laboratory co-payment as part of any debt reduction package. AACC wrote separately to House and Senate Members of the Joint Select Committee on Deficit Reduction to oppose the establishment of a clinical laboratory co-payment as part of any debt reduction package.","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2011-10-04T15:02:34.957000-04:00
1144849,34947c73-2a84-4032-9ca2-13ecde8cf4b2,Q3,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2011,third_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and  Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,59600,0,0,2011-10-05T09:52:10.183000-04:00
1145271,2221c236-6dc6-4019-a109-21deac805794,Q3,GRIZZLE COMPANY,16987,UNIVERSITY OF LOUISVILLE,2011,third_quarter,MED,Request support for NIH grant application,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2011-10-06T14:41:45.107000-04:00
1145310,2dae1811-1072-469a-8f14-42947d0344d3,Q3,ASSN OF MEDICAL DEVICE REPROCESSORS,291732,ASSN OF MEDICAL DEVICE REPROCESSORS,2011,third_quarter,MED,"Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2011-10-06T15:30:16.683000-04:00
1145525,aee4906c-1b89-4370-a926-ba1704c67c80,Q3,CEPHEID,400270233,CEPHEID,2011,third_quarter,MED,"See page five Lobbying Issues: molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs
CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding
comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues
HR 436/ S 17, Protect Medical Innovation Act of 2011
HR 488, Save Our Medical Devices Act of 2011
HR 755, Investing in Our Future Act of 2011
HR 965/ S 1211, Preservation of Antibiotics for Medical Treatment Act of 2011
HR 2182 Generating Antibiotic Incentives Now (GAIN)
S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE",,40000,0,0,2011-10-07T14:02:11.433000-04:00
1145554,5dfd0530-8a0b-4713-9d2e-b86105d8a8a8,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,DISCOVERY LABORATORIES,2011,third_quarter,MED,"Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",20000,,0,0,2011-10-07T14:40:34.010000-04:00
1145561,c72e8950-7683-4433-82f7-e49d60cf335e,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,"BRIGHTON BIOTECH, INC.",2011,third_quarter,MED,"Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",16000,,0,0,2011-10-07T14:54:35.007000-04:00
1145569,251b9293-0b6c-44e1-a563-4fd9c590ee7f,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION),2011,third_quarter,MED,"Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",46000,,0,0,2011-10-07T15:01:38.040000-04:00
1145584,53f3c3bd-24c3-41fc-9e7a-4139c11e1744,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,SANOFI PASTEUR,2011,third_quarter,MED,"Vaccine research and development legislation, funding, appropriations and oversight.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office",46000,,0,0,2011-10-07T15:13:50.350000-04:00
1145714,033a2194-e133-44e8-88ec-e370a868f0bc,Q3,BEN BARNES GROUP LP,5415,FAIR LABORATORY PRACTICES ASSOCIATION,2011,third_quarter,MED,Bring attention to prevention of unfair billing practices by laboratories for Medicare services,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-08T14:19:11.060000-04:00
1145722,619c48d5-e6df-4ef3-b0e6-d818720a4cf7,Q3,BEN BARNES GROUP LP,5415,HUNTSMAN CANCER INSTITUTE,2011,third_quarter,MED,Medical Research,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2011-10-08T15:08:14.437000-04:00
1145794,5da5ad5d-8592-4a5f-bf61-c22c2e0b2695,Q3,"FEDERAL SOLUTIONS, LLC",311371,JACKSONVILLE STATE UNIVERSITY,2011,third_quarter,MED,"Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research, education, and development","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-10T10:21:30.523000-04:00
1145810,7710b85b-4a2e-4fd5-a684-1b2cf0d9968d,Q3,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2011,third_quarter,MED,"Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research","Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2011-10-10T10:30:34.057000-04:00
1146244,5b2d1981-5519-43cd-865d-7ef2e3043ff8,Q3,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2011,third_quarter,MED,"NIH Budget including Title VII & VIII programs
VA-Outpatient Clinic in N.C.(RFP-land acquisition)
America Invents Act HR1249","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA)",,160000,0,0,2011-10-11T10:51:25.287000-04:00
1146318,bcea67cd-d33e-429b-bf27-1a188807fec8,Q3,HOLLAND & KNIGHT LLP,18466,"SHIRE PHARMACEUTICALS, INC",2011,third_quarter,MED,"Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products.  Participate in FDA stakeholder meetings re Prescription Drug User Fee program.  Met with FDA officials regarding programs to support development of products for rare diseases.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2011-10-11T11:32:09.710000-04:00
1146321,df45bb38-c683-42c7-acea-e5c0bcbd514e,Q3,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2011,third_quarter,MED,"Advocate for funding for regenerative medicine companies and researchers in universities; Advocate for NIH funding for regenerative medicine research. Advocate for funding for the FDA.   Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE",80000,,0,0,2011-10-11T11:32:10.710000-04:00
1146643,32208465-8c64-4443-8a60-8ee06580b950,Q3,NATIONAL VENTURE CAPITAL ASSOCIATION,21687,NATIONAL VENTURE CAPITAL ASSOCIATION,2011,third_quarter,MED,Personalized medicine: working with Congress to establish a regulatory approval and reimbursement path for advanced diagnostic products.  NVCA submitted comments to FDA and CMS on their FDA/CMA parallel review draft proposal,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office",,506930,0,0,2011-10-11T15:36:10.037000-04:00
1147027,fa287894-a420-44b6-865a-af8e892638d2,Q3,"THE PETRIZZO GROUP, INC.",305932,"FATE THERAPEUTICS, INC.",2011,third_quarter,MED,Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine for muscle regeneration by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.,"Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-12T11:31:28.647000-04:00
1147217,3a26c701-7fdb-46c7-9013-4c48baf81f74,Q3,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CANCER CARE ALLIANCE,2011,third_quarter,MED,"Advocated for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-12T13:25:19.457000-04:00
1147235,203cd8bb-e3ac-417c-80f1-be21e6b479f8,Q3,"THE PETRIZZO GROUP, INC.",305932,"SAGE THERAPEUTICS, INC.",2011,third_quarter,MED,"Advocated for federal funding to support development of neuroactive steroids to yield therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-12T13:34:30.983000-04:00
1147245,bc7e9ef2-b566-44a4-8696-fbcf758096b1,Q3,"THE PETRIZZO GROUP, INC.",305932,SEATTLE BIOMEDICAL RESEARCH INSTITUTE,2011,third_quarter,MED,Advocated for funding to support next-generation drug development for Leishmaniasis.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2011-10-12T13:45:36.140000-04:00
1147280,307c8298-4f44-4c2a-b289-f4fa15e1e83b,Q3,"THE PETRIZZO GROUP, INC.",305932,FRED HUTCHINSON CANCER RESEARCH CENTER,2011,third_quarter,MED,"Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011federal funding.
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-12T14:04:58.547000-04:00
1147327,d1674a51-1932-49f4-888a-6fe424e0603d,Q3,PALMETTO GROUP,18570,INTERNATIONAL AIDS VACCINE INITIATIVE,2011,third_quarter,MED,"Federal Funding of AIDS vaccine
S.1601 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012",SENATE,,,0,0,2011-10-12T14:37:28.943000-04:00
1147376,e19cb891-9059-416e-bb6d-e422e9e18546,Q3,AMERICAN ASSOCIATION OF COLLEGES OF NURSING,66911,AMERICAN ASSOCIATION OF COLLEGES OF NURSING,2011,third_quarter,MED,"Lobbied Members of Congress for additional nursing research funding in the FY 2012 LHHS Appropriations through the National Institutes of Health, National Institute of Nursing Research, and the Agency for Healthcare Research and Quality.","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Indian Health Service,Natl Institutes of Health (NIH),SENATE",,25000,0,0,2011-10-12T15:29:49.017000-04:00
1147472,3f3e16db-cac7-41d0-859c-285ce91eef01,Q3,"MEHLMAN CONSULTING, INC.",284950,NATIONAL VENTURE CAPITAL ASSOCIATION,2011,third_quarter,MED,FDA reform:  Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs.,"HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",60000,,0,0,2011-10-12T16:48:45.153000-04:00
1147665,58fc1020-4a8d-4530-80cc-f96708bd64d6,Q3,FAEGRE BAKER DANIELS CONSULTING,34158,ARTHRITIS FOUNDATION,2011,third_quarter,MED,"NIH RESEARCH, CDC PUBLIC HEALTH, MEDICARE, CHILDREN'S HEALTH","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-10-13T10:37:44.883000-04:00
1148198,c4406b28-186e-4e36-9be1-8fd275aa764a,Q3,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2011,third_quarter,MED,Legislation and issues related to Alzheimer's Disease Research,"Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,SENATE,White House Office",10000,,0,0,2011-10-13T15:22:10.263000-04:00
1148353,8b30ccf2-9c78-4d72-8a64-f3e2ef40c9f6,Q3,EDWARDS WILDMAN PALMER LLP,400309447,"ELUSYS THERAPEUTICS, INC.",2011,third_quarter,MED,Assisting with PAHPA reauthorization.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-13T16:16:41.777000-04:00
1148409,78698d2e-c673-4e59-8e7a-2f3ed06775c0,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AIDS HEALTHCARE FOUNDATION,2011,third_quarter,MED,"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011 - Support funding for medical treatment for HIV positive patients.  Support appropriate funding for the ADAP program. 
Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-13T16:57:24.403000-04:00
1148707,829b04ee-2c72-4971-9e4f-52ac45b859b7,Q3,WASHINGTON UNIVERSITY IN ST. LOUIS,40031264,WASHINGTON UNIVERSITY IN ST LOUIS,2011,third_quarter,MED,"General advocacy for NIH research, genomics research, and improved conflict of interest policies.  Advocacy in support of clear, productive federal stem cell research guidelines.","HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",,40000,0,0,2011-10-14T10:37:48.800000-04:00
1148728,6290d40a-07c8-49cc-8810-9d234f4e9229,Q3,AMERICAN DIABETES ASSOCIATION,2230,AMERICAN DIABETES ASSOCIATION,2011,third_quarter,MED,"H.R. 4808, the Stem Cell Enhancement Act.  Support bill.  Legislation codifies the Obama Administrations Executive Order and National Institutes of Health guidelines regarding federal funding of human embryonic stem cell research. (Lobbyists used: Lisa Cox)","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE",,141000,0,0,2011-10-14T10:49:18.127000-04:00
1148831,0ef6ef17-6e92-472d-a1c6-ac03948e1563,Q3,FAEGRE BAKER DANIELS CONSULTING,34158,LEARNING & EDUCATION ACADEMIC RESEARCH NETWORK,2011,third_quarter,MED,NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT RESEARCH GRANTS,"Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE",10000,,0,0,2011-10-14T11:33:09.453000-04:00
1149226,2ec0df53-b1e8-4170-b1bb-4cf6d169e653,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,PATH,2011,third_quarter,MED,Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-10-14T13:58:48.053000-04:00
1149333,b976e1dc-064b-47d3-b6ce-e08626211ac4,Q3,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION,2011,third_quarter,MED,Advocated for legislation to create pediatric research hubs to maximize the impact of existing pediatric research capacity and boost funding for research benefitting children.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-14T14:32:36.037000-04:00
1149473,f8628f61-0660-41d2-96ec-1d465817c7cc,Q3,FOLEY & LARDNER LLP,15042,"ROMARK LABORATORIES, LC",2011,third_quarter,MED,Sale of new anti-viral drug,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2011-10-14T15:28:47.940000-04:00
1149483,97e95db4-6f69-4598-9d0e-d16d83dd6683,Q3,FOLEY & LARDNER LLP,15042,PHOENIX NUCLEAR LABS LLC,2011,third_quarter,MED,Legislation to promote development of radio-isotopes for medical diagnostics and therapy,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2011-10-14T15:32:56.410000-04:00
1149550,489d5dff-aad1-44da-bd87-fe44dd9b156c,Q3,FOLEY & LARDNER LLP,15042,"FLUGEN, INC.",2011,third_quarter,MED,Funding for vaccine research and development and vaccine delivery product.,"Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2011-10-14T15:46:32.113000-04:00
1149662,c4a46ded-605e-4858-b45e-587c99f6beaf,Q3,"TCH GROUP, LLC",51478,SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ),2011,third_quarter,MED,General discussion regarding the reauthorization of the Prescription Drug User Fee Act (PDUFA); and education and awareness of vaccine production and infrastructure needs,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2011-10-14T16:43:46.377000-04:00
1149707,0c8bac11-72d1-48c5-9834-62cb90e1ac94,Q3,GROUP HEALTH COOPERATIVE,17022,GROUP HEALTH COOPERATIVE,2011,third_quarter,MED,"Issues related to health reform legislation and regulation including Medicare Advantage; insurance regulation changes; insurance
taxes; health cooperatives; health systems reserach topics such as the patient-centered medical home; the Patient Protection and
Affordable Care Act.","Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,White House Office",,110000,0,0,2011-10-14T16:57:08.283000-04:00
1149865,58e745a6-de76-4797-bca3-610ec40fe895,Q3,"THE CJR GROUP, INC.",288293,STERIS CORPORATION,2011,third_quarter,MED,Biomedical issues,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-15T09:57:41-04:00
1149869,98f66d88-e0b0-44d9-908e-39f6ad517a6c,Q3,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2011,third_quarter,MED,Medical issues relating to hospitals,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-15T10:03:42.827000-04:00
1149926,561040be-9752-4a6f-a717-9ef08ec177cc,Q3,BEN BARNES GROUP LP,5415,OKLAHOMA RESEARCH MEDICAL FOUNDATION,2011,third_quarter,MED,Medical Research,SENATE,20100,,0,0,2011-10-15T14:05:06.447000-04:00
1149996,33733fdc-3fa5-48c0-8ad0-c101c56377dc,Q3,PERSONALIZED MEDICINE COALITION,40046362,PERSONALIZED MEDICINE COALITION,2011,third_quarter,MED,"CER, CMS, Coverage of Genetic Testing","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,6499,0,0,2011-10-15T22:04:07.350000-04:00
1150045,3e5e0971-47ae-4066-bcc2-dadc8bf82e6f,Q3,AKIN GUMP STRAUSS HAUER & FELD,682,NOVARTIS CORPORATION,2011,third_quarter,MED,Issues related to the importance of vaccines,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2011-10-16T15:55:25.207000-04:00
1150596,29be2f14-bdd6-49db-975d-37b3414664f7,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ONYX PHARMACEUTICALS,2011,third_quarter,MED,"Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for 
rare diseases.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-17T11:27:41.357000-04:00
1150688,9f449e49-7144-492d-afca-32c4abadf2da,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,"NAVIGENICS, INC.",2011,third_quarter,MED,"Oversight and regulation of genetic testing.
Direct to consumer genetic testing.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-10-17T11:51:25.530000-04:00
1150716,b72a1368-daff-4b5b-86e3-b2f75ffbc94d,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TETHYS BIOSCIENCE,2011,third_quarter,MED,"Regulation of laboratory developed tests.
No Bill #: BETTER Patient Care Act","Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-17T11:59:37.277000-04:00
1150735,cc03d1f0-ab20-4358-a88a-c1709d79b437,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION FOR MOLECULAR PATHOLOGY,2011,third_quarter,MED,"Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics.
No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, American Invents Act","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE",30000,,0,0,2011-10-17T12:10:47.873000-04:00
1150865,011af3e5-b0d4-4a7f-95c2-7488af7a44c9,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL HEMOPHILIA FOUNDATION,2011,third_quarter,MED,"Hemophilia research, prevention, surveillance and service programs and issues.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2011-10-17T12:53:39.483000-04:00
1150890,19a6ea21-be07-46dc-8ed6-dd025ae04b73,Q3,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2011,third_quarter,MED,upcoming reauthorization of Prescription Drug User Fee Act and Medical Device User Fee Act,"HOUSE OF REPRESENTATIVES,SENATE",,15000,0,0,2011-10-17T12:59:51.013000-04:00
1150906,d9a45920-ecaa-42b0-a281-2d0831b1b6dd,Q3,CALIFORNIA LIFE SCIENCES,7758,CALIFORNIA LIFE SCIENCES,2011,third_quarter,MED,Support NIH funding.,"HOUSE OF REPRESENTATIVES,SENATE",,140000,0,0,2011-10-17T13:01:54.560000-04:00
1150908,3ea52269-8e4a-4232-b2f3-6227f856e7fe,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2011,third_quarter,MED,Research in hematology.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2011-10-17T13:02:55.513000-04:00
1150925,284930a8-0040-49c5-a746-ea87f306d2ae,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION OF AMERICA'S BLOOD BANKS,2011,third_quarter,MED,"Blood safety and management issues.  HHS Advisory Committee on Blood Safety and Availability. 
Research related to Biovigilance.","Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-17T13:07:03.683000-04:00
1150944,d5f5a18f-f54e-4121-b136-cfee33319b54,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION,2011,third_quarter,MED,"S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research
HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease
HR 640, Bone Marrow Failure Disease Research and Treatment Act","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2011-10-17T13:17:14.450000-04:00
1150962,040042d9-510b-4303-99eb-596a7eb418b4,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION,2011,third_quarter,MED,"S. 1599, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research
HR 2123/S 1167, Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011.","Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-17T13:20:19.687000-04:00
1151050,208b4c5c-afbe-45b1-beee-01356877a028,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2011,third_quarter,MED,"S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, Tuberous Sclerosis
HR 1473, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program","Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2011-10-17T14:05:49.277000-04:00
1151070,87b2f34d-92b1-4eff-8e09-d4f3df1fdd02,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,"SAGE PUBLICATIONS, INC.",2011,third_quarter,MED,"No Bill#, Federal Research Public Access Act
National Institutes of Health Open Access policy
No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, NIH Open Access Policy, Department of Education Title II Funding No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-17T14:09:54.977000-04:00
1151112,66e7e4b3-9a6d-428e-a417-d5b980417981,3T,"BALCH & BINGHAM, LLP",5197,BIOCRYST PHARMACEUTICALS INC,2011,third_quarter,MED,"Programs, regulations and legislation pertaining to: Project Bioshield; Federal pandemic preparedness and response; the Biomedical Advanced Research and Development Authority; the Food & Drug Administration.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,1,2011-10-17T14:21:15.357000-04:00
1151137,9e878fe1-f6fa-4160-ad8f-1275a08de954,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2011,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2011-10-17T14:27:27.150000-04:00
1151186,128133c7-36ec-4fb9-8aa1-c54f21cf7ff1,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2011,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2011-10-17T14:36:45.987000-04:00
1151287,35ac5cb3-41cd-4fa4-a552-c1c7eddd7c9c,Q3,POLICY DIRECTIONS INC.,31747,BAYLOR COLLEGE OF MEDICINE,2011,third_quarter,MED,"S. 606  and HR 3059- Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment.
HR 528 - Neglected Infections of Impoverished Americans Act of 2011.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-17T14:56:25.567000-04:00
1151291,13671ab3-e55e-48b6-824d-c88b2a18c0fe,Q3,AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS,1375,AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS,2011,third_quarter,MED,Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ),"Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE",,7087,0,0,2011-10-17T14:59:28.850000-04:00
1151424,083d9071-19ea-483c-bfd0-464b908be417,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2011,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2011-10-17T15:22:15.357000-04:00
1151450,9b1a94b1-063d-442e-9416-24e4290aeeb5,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2011,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2011-10-17T15:28:25.090000-04:00
1151517,5d125bb2-465d-433b-bbe4-a640a626165f,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2011,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2011-10-17T15:37:42.997000-04:00
1151574,f3e7b773-a448-4821-9bdb-a26fb6a5da35,Q3,"THE CORMAC GROUP, LLC",66773,KESSLER FOUNDATION,2011,third_quarter,MED,"Appropriations, DOD","HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2011-10-17T15:56:11.530000-04:00
1151632,f81d38f5-35a9-4e6e-bf20-78eafbf9f695,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,STATE UNIVERSITY SYSTEM OF FLORIDA,2011,third_quarter,MED,"Appropriations and Authorization legislation for FY 2012 in health care
HR3070/S.1599","Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",70000,,0,0,2011-10-17T16:10:30.870000-04:00
1151671,6265b7ba-762d-4d2b-9318-74c16548ca86,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ),2011,third_quarter,MED,General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA); and education and awareness of vaccine production and infrastructure needs.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-17T16:25:46.260000-04:00
1151682,085b22e0-e9e7-4b62-8fe4-00cb9248c010,3A,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,STATE UNIVERSITY SYSTEM OF FLORIDA,2011,third_quarter,MED,"Appropriations and Authorization legislation for FY 2012 in health care
HR3070/S.1599","Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",70000,,0,0,2011-10-17T16:28:49.560000-04:00
1151687,6b4c5ba0-469d-44e1-a947-e42ab05cea35,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE,2011,third_quarter,MED,Public Health Programs for Infectious and Tropical Disease; Issues related to Neglected Disease Product Approval; H.R. 528 - Neglected Infections of Impoverished Americans Act; CDC Infection and Vector Borne Disease Programs; S. Con. Res. 115 - World Malaria Day Resolution; S. 606 - Creating Hope Act of 2011; H.R. 2144 - 21st Century Global Technology Act.,"Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID)",30000,,0,0,2011-10-17T16:29:51.230000-04:00
1151693,64aacadc-beab-4af9-aa39-d777724f4eca,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,RIVERAIN MEDICAL,2011,third_quarter,MED,Increasing awareness of lung cancer and making it a public health priority,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-17T16:32:55.747000-04:00
1151704,83a252ac-333e-41c4-a1b4-5024059ed668,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PREVENT BLINDNESS,2011,third_quarter,MED,Eye Disease and Vision Health; Treatment and Prevention of Blindness and Vision Loss.,"Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",40000,,0,0,2011-10-17T16:35:00.823000-04:00
1151793,b551e569-42f3-415c-87ae-a5accbc0f882,Q3,LATHAM & WATKINS LLP,22201,BOSTON SCIENTIFIC CORPORATION,2011,third_quarter,MED,Congressional oversight of the Food and Drug Administration.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-10-17T16:53:39.997000-04:00
1151796,5151403a-f776-484b-9551-ac9ad4618b05,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,COOLEY'S ANEMIA FOUNDATION,2011,third_quarter,MED,Drug review and approval process,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-17T16:53:41.293000-04:00
1151810,36c5b0ec-c9e1-4e03-a0fc-2548f1e67945,Q3,INFECTIOUS DISEASES SOCIETY OF AMERICA,54836,INFECTIOUS DISEASES SOCIETY OF AMERICA,2011,third_quarter,MED,Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; and support for evidence-based decision making.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID)",,102889,0,0,2011-10-17T16:54:45.730000-04:00
1151844,ad0bab1b-5c36-4274-90e1-a79aa0e18b05,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,"SMITH & NEPHEW, INC.",2011,third_quarter,MED,Issues Related to Arthritis.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Veterans Affairs, Dept of (VA)",50000,,0,0,2011-10-17T16:59:59.167000-04:00
1151882,4f0d7d00-ab66-4f98-888f-e7d6a380859a,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PREECLAMPSIA FOUNDATION,2011,third_quarter,MED,Preeclampsia Research; National Health Calendar.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH)",10000,,0,0,2011-10-17T17:03:11.637000-04:00
1151920,1428fc21-f0e9-4d83-a8d5-d655beeb4b33,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA,2011,third_quarter,MED,Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-10-17T17:07:25.370000-04:00
1151961,3f5d9940-36f2-4aee-8b3b-dc280a6aa31c,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,SPINA BIFIDA ASSOCIATION,2011,third_quarter,MED,Spina Bifida Research and Awareness and Access to Care; Medical Device User Fee Act.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE",40000,,0,0,2011-10-17T17:15:46.650000-04:00
1152177,820c60ce-4f5a-4ea4-8b0f-4e97168636c6,Q3,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2970,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2011,third_quarter,MED,"No bill #: Advocate for disability and rehabilitation prioirities of the Patient Centered Outcomes Research Institute, espcially regarding comparative effectiveness research.  Advocate for elevation of the National Center for Medical Rehabilitation Research within the National Institutes of Health.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE",,100000,0,0,2011-10-17T18:21:09.683000-04:00
1152546,1619f355-69df-4b5a-a3df-90bdf7e0071b,Q3,VAN SCOYOC ASSOCIATES,39837,"CORPORATE FRIENDS OF CDC, INC.",2011,third_quarter,MED,No lobbying activity.,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-10-18T06:19:15.483000-04:00
1152787,2e9f7b26-aa5d-4f2b-9eaa-f068cebbc6f9,Q3,SRI INTERNATIONAL,90990,SRI INTERNATIONAL,2011,third_quarter,MED,"FY12 House and Senate Defense Appropriations (HR 2219)
FY12 House and Senate Defense Authorizations (HR 1540/S 1253)
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (HR 2405)","HOUSE OF REPRESENTATIVES,SENATE",,90000,0,0,2011-10-18T09:40:53.100000-04:00
1152925,3bf1a73b-902a-4235-ab5d-c840764d4243,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,COALITION FOR 21ST CENTURY MEDICINE,2011,third_quarter,MED,Issues concerning regulation of laboratory tests.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2011-10-18T10:10:48.797000-04:00
1152995,2b095093-1d54-4d83-9329-946b69a71fdd,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,GENOMIC HEALTH INC,2011,third_quarter,MED,"FDA regulation of laboratory-developed tests.
Medicare reimbursement for laboratory-developed tests.","Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2011-10-18T10:20:19.173000-04:00
1153072,800182f1-4d4f-4ce8-afc7-7c8cf281ec33,Q3,DENNY MILLER ASSOCIATES,25328,CELL THERAPEUTICS,2011,third_quarter,MED,FDA appeal process for new drug applications. FDA process for approving clinical trials for new drug applications. Federal support for biotechnology companies.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-18T10:26:49.823000-04:00
1153186,8a858f76-c937-4718-bdab-d786c9a08bee,Q3,BLANK ROME GOVERNMENT RELATIONS,6325,SELECT GREATER PHILADELPHIA (FORMERLY LISTED AS THE CEO COUNCIL FOR GROWTH),2011,third_quarter,MED,Issues relating to laboratory space,Centers For Disease Control & Prevention (CDC),20000,,0,0,2011-10-18T10:41:37.150000-04:00
1153995,e7321ce9-c751-422d-84ce-8c6334d72b4a,Q3,DENNY MILLER ASSOCIATES,25328,SABEY CORPORATION,2011,third_quarter,MED,"Oversight and implementation of the Patient Protection and Affordable Care Act (PL 111-148), provisions relating to the Center for Medicare and Medicaid Innovation grant program. Federal grant funding through the Department of Health and Human Services.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-10-18T13:02:07.807000-04:00
1154064,659ebcdc-74d1-41a5-94ae-6f55c989bc2a,Q3,"GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC)",33124,IMX MEDICAL MANAGEMENT SERVICES,2011,third_quarter,MED,No specific legislative activities - .Continued to meet with members of Pennsylvania Congressional delegation to brief them on IMX's efforts to have their medical evaluation services given consideration by the Department of Veterans Affairs and the Department of Defense.  Also held meetings with officials at Department of Veterans Affairs and Department of defense to discuss their procurement procedures for additional medical services.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",5000,,0,0,2011-10-18T13:10:32.633000-04:00
1154072,a83a85b1-4e0a-444f-acc8-a14f0d11a1c4,Q3,PARKINSON'S ACTION NETWORK,285676,PARKINSON'S ACTION NETWORK,2011,third_quarter,MED,"H.R. 2595/S.425, ""The National Neurological Diseases Surveillance System Act,"" all sections; ""all sections relating to the National Insitutes of Health (NIH), Cures Acceleration Network, and the National Center for Advancing Translational Sciences""; ""Department of Defense Appropriations,"" sec. related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) progarm; Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2012,"" all sections FDA; Prescription Drug User Fee Act (PDUFA) V; Medical Device User Fee Act (MDUFA) IV; the Balanced Budget Act of 1997 (sections related to amending Medicare therapy caps).","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2011-10-18T13:11:35.633000-04:00
1154080,1146836b-34ef-4f46-9230-16c6bdd0edb3,Q3,"CASSIDY & ASSOCIATES, INC.",8453,"LINDE NORTH AMERICA, INC.",2011,third_quarter,MED,"Legislation related to the Food and Drug Administration 
HR2227, the Medical Gas Act","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-18T13:12:38.837000-04:00
1154192,6ac6391f-ca11-4dea-8cbb-a1bd5ff1d941,Q3,DENNY MILLER ASSOCIATES,25328,ST PATRICK HOSPITAL AND HEALTH SCIENCE CENTER,2011,third_quarter,MED,"S 1599, Labor, Health and Human Services, and Education Appropriations Bills, FY 2012, Title II, provisions relating to rural health care.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-10-18T13:32:24.037000-04:00
1154253,5abcd4be-349c-415a-9cdb-60cddbf83f39,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,NATIONAL PSORIASIS FOUNDATION,2011,third_quarter,MED,"H.R. 2033/S.1107 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; Psoriasis Data Collection.","Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,White House Office",50000,,0,0,2011-10-18T13:39:49.900000-04:00
1154300,40375ee4-b261-4dc2-b062-3306941d1e98,Q3,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,ABBOTT LABORATORIES,2011,third_quarter,MED,Healthcare reform,,60000,,0,0,2011-10-18T13:49:13.727000-04:00
1154410,22972ccc-8af4-40dc-ba68-1924775b590d,Q3,PARALYZED VETERANS OF AMERICA,30724,PARALYZED VETERANS OF AMERICA,2011,third_quarter,MED,"Department of Veterans Affairs, Medical Research Issues
National Institutes of Health, Medical Research Issues","HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)",,81128,0,0,2011-10-18T14:09:01.777000-04:00
1154628,0e66da02-3012-4a12-9b4c-ceab8527cda8,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,ISIS PHARMACEUTICALS,2011,third_quarter,MED,"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.  Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2011-10-18T14:31:28.007000-04:00